← All stocks

Quince Therapeutics, Inc.

QNCX Net selling
CIK 0001662774 #4870 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$173.50K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$173.50K
1 of 1 sales
Net
−$173.50K
−$173.50K against sales at will

By person

4 insiders · 3 transactions
6.2×

Dirk Thye holds 6.2 times base salary in stock. $3.45M of shares against $550.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dirk Thye last reported holding, valued at $3.47, the price Common Stock was last bought or sold at on the open market here, on 26 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Benatti Luca
Director
$173.50K (1)
−$173.50K
39,179
$135.95K
−51.2%
Thye Dirk
CEO and CMO
994,885
$3.45M
+17.9%
Hannah Brendan
CBO, COO & CCO
361,827
$1.26M
+22.0%
Ryan Charles S.
President
130,009
$451.13K
+6.2%

No percentages here. This company's share count has moved by a factor of 160.3 over the window, from 1,017,063 to 163,007,943 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Benatti Luca
26 Dec 2025
Director
Sell
50,000
$3.47
$173.50K

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 1,507,321
History held since 9 May 2019